Thromboembolic complications and abnormal bleeding are among the major complications of valvular heart disease, artificial heart valves, cardiopulmonary bypass and ventricular assist devices. The mechanisms by which platelets and the blood coagulation system are activated in these conditions are incompletely understood. There is evidence that both interaction of platelets with foreign surfaces or the diseased vasculature and effects of fluid shear stress are involved in the activation of platelets and that these processes can be modified by red blood cells (RBC) and products of the vessel wall. The studies proposed here are designed to examine in detail: 1. The mechanisms by which well-defined, uniform, laminar fluid shear stress (in the range that may be encountered in vivo) triggers platelet reactions (release of platelet granule contents, platelet aggregation, platelet procoagulant availability) and causes platelet damage; 2. The effects of exposure of normal platelets and """"""""hypersensitive"""""""" platelets (from patients with conditions associated with premature atherosclerotic disease) to both prolonged, steady, and to biologically more relevant, repetitive short-term shear stresses on in vitro function and in vivo survival; 3. The effects of normal and abnormal (impaired deformability, abnormal size) RBC on shear-induced platelet alterations; 4. The effects of normal and abnormal (atherosclerotic) vascular surfaces on platelet reactions in laminar shear flow. The results of these studies should provide important basic information in regard to the responses of platelets to fluid shear stress in vitro and vivo and may aid in the development of better strategies for both prevention and treatment of thrombotic and hemorrhagic complications with artificial cirulatory devices and atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL028227-04A1
Application #
3339651
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
1982-01-01
Project End
1988-11-30
Budget Start
1985-12-01
Budget End
1986-11-30
Support Year
4
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Saint Louis University
Department
Type
Schools of Medicine
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63103
Domoto, D T; Bauman, J E; Joist, J H (1991) Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thromb Res 62:737-43
Sutera, S P; Nowak, M D; Joist, J H et al. (1988) A programmable, computer-controlled cone-plate viscometer for the application of pulsatile shear stress to platelet suspensions. Biorheology 25:449-59
Leyva, W H; Knutsen, A P; Joist, J H (1988) Disappearance of a high response factor VIII inhibitor in a hemophiliac with AIDS. Am J Clin Pathol 89:414-8
Reimers, H J; Baker, R K; Joist, J H (1987) Impaired thromboxane synthesis in preactivated human blood platelets: agonist-specific, irreversible desensitization to thrombin. Thromb Res 48:535-48
Bauman, J E; Reimers, H J; Joist, J H (1987) Deaggregation of in vitro-degranulated human platelets: irreversibility of aggregation may be agonist-specific rather than related to secretion per se. Thromb Haemost 58:899-904
Joist, J H; Pennington, D G (1987) Platelet reactions with artificial surfaces. ASAIO Trans 33:341-4
Chopra, J; Joist, J H; Webster, R O (1987) Loss of 51chromium, lactate dehydrogenase, and 111indium as indicators of endothelial cell injury. Lab Invest 57:578-84
Janney, S K; Joist, J J; Fitch, C D (1986) Excess release of ferriheme in G6PD-deficient erythrocytes: possible cause of hemolysis and resistance to malaria. Blood 67:331-3
Martin, T W; Joist, J H; Bauman, J E et al. (1985) Activation of human platelets by N-substituted aminophospholipids. J Biol Chem 260:2852-6